Inhibition of phosphoinositide 3-kinase impairs precommitment cell cycle traverse and prevents differentiation in erythroleukaemia cells

Cell Death and Differentiation

Volumn 7, Issue 1, 2000, Pages 112-117

  Bavelloni, A ^b   Faenza, I ^e   Aluigi, M ^b   Ferri, A ^e   Toker, A ^c   Maraldi, N M ^a,b   Marmiroli, Sandra ^a,d  

^a CNR   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^d Ist Citomorfologia Normale P   (Italy)

^e NONE

Author keywords

Cell cycle; Cyclin D3; Differentiation; GATA; PI 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN D3; DIMETHYL SULFOXIDE; DNA; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR GATA 1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROLEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION;

ANIMALIA;

EID: 0034103118     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400591     Document Type: Article

References (26)

1. Marks PA, Richon VM, Kiyokawa H and Rifkind RA (1994) Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. Proc. Natl. Acad. Sci. USA 91: 10251-10254
2. Kiyokawa H, Richon VM, Venta-Perez G, Rifkind RA and Marks PA (1993) Hexamethylenebisacetamide-induced erythroleukemia cells differentiation involves modulation of events required for cell cycle progression through G1. Proc. Natl. Acad. Sci. USA 90: 6746-6750
3. Fibach E, Reuben RC, Rifkind RA and Marks PA (1977) Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. Cancer Res. 37: 440-444
4. Toker A, and Cantley LC (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 378: 673-676
5. Fruman DA, Meyers RE and Cantley LC (1998) Phosphoinositide kinases. Annu. Rev. Biochem. 67: 481-507
6. Ui M, Okada T, Hazaki K and Hazaki O (1995) Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem. Sci. 20: 303-307
7. Kimura K, Hattori S, Kabuyama Y, Shizawa Y, Takayanagi J, Nakamura S, Toki S, Matsuda Y, Onodera K and Fukui Y (1994) Neurite outgrowth of PC12 cel s is suppressed by wortmannin, a specific inhibitor of Phosphatidylinositol 3-kinase. J. Biol. Chem. 269: 18961-18967
8. Jiang BH, Zheng JZ and Vogt PK (1998) An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc. Natl. Acad. Sci. USA 95: 14179-14183.
9. Kaliman P, Vinals F, Testar X, Palacin M and Zorzano A (1996) Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 271: 19146-19151
10. Bertagnolo V, Neri LM, Marchisio M, Mischiati C and Capitani S (1999) Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res. 59: 542-546
11. Orkin SH (1995) Hematopoiesis: how does it happen? Curr. Opin. Cell. Biol. 7: 870-877
12. Crossley M and Orkin SH (1994) Phosphorylation of the erythroid transcription factor GATA-1. J. Biol. Chem. 269: 16589-16596
13. Downward J (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell. Biol. 10: 262-267
14. Duronio V, Scheid MP and Ettinger S (1998) Downstream signalling events regulated by phosphostidylinositol 3-kinase activity. Cell Signal 10: 233-239
15. Kiyokawa H, Richon VM, Rifkind RA and Marks PA (1994) Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol. Cell. Biol. 14: 7195-7203
16. Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA and Marks PA (1996) Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc. Natl. Acad. Sci. USA 93: 5705-5708
17. Klippel A, Escobedo MA, Wachowicz MS, Apell G, Brown TW, Gieldin MA, Kavanaugh WM and Williams LT (1998) Activation of Phosphatydilinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol. 18: 5699-5711
18. Muise-Helmericks RC, Leighton Grimes H, Bellacosa A, Malstrom SE, Tsichlis PN and Rosen N (1998) Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/AKT-dependent pathway. J. Biol. Chem. 273: 29864-29872
19. S6K-independent signaling in growth factor-stimulated NIH3T3 fibroblasts. Mol. Cell. Biol. 19: 1346-1358
20. Richon VM and Venta-Perez G (1996) Changes in E2F DNA-binding activity during induced erythroid differentiation. Cell. Growth Differ. 7: 31-42
21. Jackowski S (1996) Cell cycle regulation of membrane phospholipid metabolism. J. Biol. Chem. 271: 20219-20222
22. Sun B, Murray N R and Fields AP (1997) A role for nuclear phosphatidylinositol-specific phospholipase C in the G2/M phase transition. J. Biol. Chem. 272: 26313-26317
23. Matteucci A, Faenza I, Gilmour RS, Manzoli L, Billi AM, Peruzzi D, Bavelloni A, Rhee SG and Cocco L (1998) Nuclear but not cytoplasmic phospholipase C β1 inhibits differentiation of erythroleukaemia cells. Cancer Res. 58: 5057-5060
24. Roche S, Koegl M and Courtneidge SA (1994) The phosphatidylinositol 3-kinase α is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. USA 91: 9185-9189
25. Marmiroli S, Bavelloni A, Faenza I, Sirri A, Ognibene A, Cenni V, Tsukada J, Koyama Y, Ruzzene M, Ferri A, Auron P, Toker A and Maraldi N M (1998) Pl 3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett. 438: 49-54
26. Ausebel FM, Brent R, Kingston RE, More DD, Seidman GJ, Smith JA and Struhl K (1994) In: Current Protocols in Molecular Biology (Greene Publishing Associates/Wiley & Sons) New York